PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1.
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1.
复制标题
PPDPF 通过调节 SOS1 的 GEF 活性促进突变 KRAS 驱动的胰腺导管腺癌的发展
DOI:
10.1002/advs.202202448
复制
发表时间:
2023-01
期刊:
影响因子:
15.1
通讯作者:
Li, Jing-Jing
中科院分区:
文献类型:
--
作者:
Ni, Qian-Zhi;Zhu, Bing;Ji, Yan;Zheng, Qian-Wen;Liang, Xin;Ma, Ning;Jiang, Hao;Zhang, Feng-Kun;Shang, Yu-Rong;Wang, Yi-Kang;Xu, Sheng;Zhang, Er-Bin;Yuan, Yan-Mei;Chen, Tian-Wei;Yin, Fen-Fen;Cao, Hui-Jun;Huang, Jing-Yi;Xia, Ji;Ding, Xu-Fen;Qiu, Xiao-Song;Ding, Kai;Song, Chao;Zhou, Wen-Tao;Wu, Meng;Wang, Kang;Lui, Rui;Lin, Qiu;Chen, Wei;Li, Zhi-Gang;Cheng, Shu-Qun;Wang, Xiao-Fan;Xie, Dong;Li, Jing-Jing
关键词:
The guanine nucleotide exchange factor (GEF) SOS1 catalyzes the exchange of GDP for GTP on RAS. However, regulation of the GEF activity remains elusive. Here, the authors report that PPDPF functions as an important regulator of SOS1. The expression of PPDPF is significantly increased in pancreatic ductal adenocarcinoma (PDAC), associated with poor prognosis and recurrence of PDAC patients. Overexpression of PPDPF promotes PDAC cell growth in vitro and in vivo, while PPDPF knockout exerts opposite effects. Pancreatic‐specific deletion of PPDPF profoundly inhibits tumor development in KRASG12D‐driven genetic mouse models of PDAC. PPDPF can bind GTP and transfer GTP to SOS1. Mutations of the GTP‐binding sites severely impair the tumor‐promoting effect of PPDPF. Consistently, mutations of the critical amino acids mediating SOS1–PPDPF interaction significantly impair the GEF activity of SOS1. Therefore, this study demonstrates a novel model of KRAS activation via PPDPF‐SOS1 axis, and provides a promising therapeutic target for PDAC. This study reveals a novel model of KRAS activation via PPDPF‐SOS1 axis. PPDPF is upregulated in pancreatic ductal adenocarcinoma. It can bind GTP and offer GTP to SOS1, which stimulates the GEF activity of SOS1 and subsequent activation of KRAS. This work provides a promising therapeutic target for PDAC.
登录
查看更多内容
影响因子:
28.2
作者:
Collisson EA;Trejo CL;Silva JM;Gu S;Korkola JE;Heiser LM;Charles RP;Rabinovich BA;Hann B;Dankort D;Spellman PT;Phillips WA;Gray JW;McMahon M
通讯作者:
McMahon M
DOI:
10.1073/pnas.1812963116
发表时间:
2019-02-12
影响因子:
11.1
作者:
Hillig, Roman C.;Sautier, Brice;Bader, Benjamin
通讯作者:
Bader, Benjamin
DOI:
10.1126/science.1250373
发表时间:
2014-07-04
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Iversen L;Tu HL;Lin WC;Christensen SM;Abel SM;Iwig J;Wu HJ;Gureasko J;Rhodes C;Petit RS;Hansen SD;Thill P;Yu CH;Stamou D;Chakraborty AK;Kuriyan J;Groves JT
通讯作者:
Groves JT
影响因子:
4.5
作者:
Cerny AC;Altendorfer A;Schopf K;Baltner K;Maag N;Sehn E;Wolfrum U;Huber A
通讯作者:
Huber A
影响因子:
4
作者:
Hobbs, G. Aaron;Der, Channing J.;Rossman, Kent L.
通讯作者:
Rossman, Kent L.